Literature DB >> 25818576

Prophylactic treatment with melatonin before recurrent neonatal seizures: Effects on long-term neurobehavioral changes and the underlying expression of metabolism-related genes in rat hippocampus and cerebral cortex.

Hong Ni1, Qi Sun2, Tian Tian2, Xing Feng2, Bao-liang Sun3.   

Abstract

Although it has been suggested that the protective effect of melatonin against seizure-induced neurotoxicity involves inhibition of neuronal lipid peroxidation, current data concerning the exact molecular mechanism are still limited. This study was undertaken to investigate the changes in neurobehavioral, cognitive and lipid metabolism-related gene expressions in both hippocampus and cerebral cortex of rats subjected to recurrent neonatal seizures, and the effects of melatonin treatment before seizure (55mg/kg, 1mg/ml). 6-day-old (P6) SD rats were randomly divided into four groups of control (CONT, the same below), melatonin treated control (Mel), recurrent neonatal seizure (RS) and melatonin and RS combination treatment (Mel+RS). Neurological behavioral parameters of brain damage (plane righting reflex, negative geotaxis reaction reflex, Cliff avoidance reflex, forelimb suspension reflex) were observed on P31. Morris water maze test was performed during P29-P35. Then the protein levels of ACAT1, Cathepsin-E and Ca(2+)/calmodulin-dependent protein kinase II (CAMK II) in hippocampus and cerebral cortex were detected by western blot method. As expected, RS group showed a significant delay or reduce of the four reflexes, as well as bad performance in the Morris water maze test. Flurothyl-induced neurobehavioral toxicology was blocked by pre-treatment with melatonin. In parallel with these behavioral changes, gene expression by western blot method demonstrated that rats pretreated with melatonin (Mel+RS) showed a significant down-regulated expression of ACAT-1, Cathepsin-E and up-regulated CAMK II in hippocampus and cerebral cortex when compared with RS group. Our findings provide support for ACAT-1/Cathepsin-E as well as CaMK II being potential targets for the treatment of neonatal seizure-induced brain damage by melatonin.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ACAT-1; CaMK II; Cathepsin-E; Melatonin; Neonatal seizure; Neurobehavioral toxicity

Mesh:

Substances:

Year:  2015        PMID: 25818576     DOI: 10.1016/j.pbb.2015.03.012

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  5 in total

Review 1.  Melatonin: A Mitochondrial Targeting Molecule Involving Mitochondrial Protection and Dynamics.

Authors:  Dun-Xian Tan; Lucien C Manchester; Lilan Qin; Russel J Reiter
Journal:  Int J Mol Sci       Date:  2016-12-16       Impact factor: 5.923

2.  Reduction of Mitophagy-Related Oxidative Stress and Preservation of Mitochondria Function Using Melatonin Therapy in an HT22 Hippocampal Neuronal Cell Model of Glutamate-Induced Excitotoxicity.

Authors:  Dan-Dan Wang; Mei-Fang Jin; Dong-Jing Zhao; Hong Ni
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-08       Impact factor: 5.555

3.  Leptin Maintained Zinc Homeostasis Against Glutamate-Induced Excitotoxicity by Preventing Mitophagy-Mediated Mitochondrial Activation in HT22 Hippocampal Neuronal Cells.

Authors:  Mei-Fang Jin; Hong Ni; Li-Li Li
Journal:  Front Neurol       Date:  2018-05-09       Impact factor: 4.003

4.  Negative geotaxis: An early age behavioral hallmark to VPA rat model of autism.

Authors:  Rakesh K Ruhela; Shringika Soni; Phulen Sarma; Ajay Prakash; Bikash Medhi
Journal:  Ann Neurosci       Date:  2019-01-01

5.  Editorial: Endocrine Modulators of Neurological Processes: Potential Treatment Targets of Pediatric Neurological Diseases.

Authors:  Hong Ni; Giuseppe Biagini; Dinesh Upadhya; Alessandro Capuano
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-18       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.